CB
THC Farmaceuticals, Inc.
CBDG · OTC
$0.02 +0.00% (+$0.00)
1M +200.00%
Market Cap $130.5K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.04x
P/FCF 0.21x
P/E N/A
Growth
84 /100
Growing Book val. growth 10.89%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
1 /100
Poor ROIC 1.09%
ROA 0.55%
Asset turnover 0.00x
Debt
81 /100
Low Debt/Equity 0.04x
Current ratio 0.12x
Net debt/EBITDA -5.59x
Stability
13 /100
Unstable Beta -8.64x
Rev. volatility 250.36%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o CBDG
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark D. Grossman
Employees
2
Headquarters
Scottsdale